Programme

This is a Provisional Conference Programme.

For further information on this event please contact us.

Thursday 8th September 2022

Welcome & Opening Remarks
Sarah Gilbert
(Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK)

Session 1:
Opening Plenary Session

‘Covid 19 pandemic – the public health angle’
Jonathan Van Tam
(University of Nottingham, Nottingham, UK)

‘Vaccine strategies for the next pandemic’
Sarah Gilbert
(Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK)

Coffee Break

Session 2:
Plenary Session

‘Corona virus presentation’
John Oxford
(Blizard Institute, Queen Mary College, London, UK)

‘A global perspective on Covid-19 vaccines’
Christopher Chadwick, Martin Friede and Ann Moen
(World Health Organization, Geneva, Switzerland)

‘A Universal Covid Vaccine? Is it the answer and is it possible?’ 
Rob Lambkin-Williams
(Virology Consult, London, UK)

Lunch Break

Session 3:
SARS-CoV-2 vaccine strategies I: Systemic / mucosal, mRNA, samRNA live-attenuated,  mosaic antigens

Overview Presentation
Prof Shan Lu
(University of Massachusetts, Worcester, Massachusetts, USA)

Questions & Answers & Open Audience Discussion

Tea Break

Session 4:
Variants of concern identification and COVID vaccine updates

‘A Universal Covid Vaccine? Is it the answer and is it possible?’ 
Rob Lambkin-Williams
(Virology Consult, London, UK)

‘Covid 19 variants presentation – current vaccines effects on variants’
Updates for:

‘Moderna Covid-19 (mRNA-1273) vaccine’
Speaker to be confirmed

Oxford/AstraZeneca vaccine
Sarah Gilbert
(Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK)

Pfizer/BioNTech vaccine
Katalin Karikó – Speaker to be confirmed
(BionTech)

‘Novavax vaccine’
Vivek Shinde
(Novavax Inc., Gaithersburg, Maryland, USA)Janssen 

Ad26.COV2.S COVID-19 vaccine’
Tobias Kamphuis
(Janssen Vaccines & Prevention, Ledien, The Netherlands)

Friday 9th September 2022

Session 5:

‘Towards “universal” coronavirus vaccines (cross-reactions with common cold CoVs)’
Teresa Lambe
(University of Oxford, Oxford, UK)

Coffee Break

Session 6:

‘New COVID vaccines – the regulatory angle’
Othmar G. Engelhardt
(NIBSC, South Mimms, Potters Bar, UK)

‘Correlates of protection, Immune monitoring and harmonisation of assays for vaccine evaluation’
Emanuele Montimoli 
(VisMederi SRl, Siena, Italy)

‘Animal models for evaluation of vaccine efficacy’
Dan Barouch – Speaker to be confirmed
(Harvard Medical School, Boston, Massachusetts, USA)

Lunch Break

Session 7:
LATEBREAKER ORAL PRESENTATIONS

Latebreaker abstracts for oral and poster presentation at CVW 2022 are called for. Please see the Participation page for details.

Tea Break

Session 8:
PANEL & AUDIENCE  DISCUSSION

‘Potential Issues: Long-covid concerns and the outlook for the potential Influenza/Covid combination in the future (and others such as MERS)’
Moderator: Sarah Gilbert
(Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK)

Closing Remarks & Departure

Latebreaker abstracts for oral and poster presentation at CVW 2022 are called for. Please see the Participation page for details.

This provisional programme is correct at the time of publication. However the organizers reserve the right to make any alterations that may be required in the interests and integrity of the conference programme.